Low Molecular Weight Heparin for VTE prophylaxis ingredient specific
retiredURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12
Version20160331
PublisherTJC EH StewardDate2016-03-31T01:00:12-04:00Purpose(Clinical Focus: Low Molecular Weight Heparins (LMWH) for VTE prophylaxis as independent ingredients for use in noting the most general idea of this type of therapy. Initial use is for representation of a medication "not done". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of LMWHs for VTE prophylaxis),(Exclusion Criteria: None)
Expansion
| Code | Display | System |
|---|---|---|
| 67109 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 67108 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 69646 | http://www.nlm.nih.gov/research/umls/rxnorm |